Predicted to enable metal ion binding activity; phosphotyrosine residue binding activity; and protein tyrosine kinase activity. Predicted to be involved in several processes, including cellular response to retinoic acid; positive regulation of establishment of T cell polarity; and synapse maturation. Predicted to act upstream of or within several processes, including T cell differentiation; nervous system development; and regulation of signal transduction. Predicted to be located in several cellular components, including dendritic spine; lamellipodium; and phagocytic cup. Predicted to be active in glutamatergic synapse; plasma membrane; and postsynapse. Orthologous to human ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase).
RGD Description
Predicted to enable metal ion binding activity; phosphotyrosine residue binding activity; and protein tyrosine kinase activity. Predicted to be involved in several processes, including cellular response to retinoic acid; positive regulation of establishment of T cell polarity; and synapse maturation. Predicted to act upstream of or within several processes, including T cell differentiation; nervous system development; and regulation of signal transduction. Predicted to be located in several cellular components, including dendritic spine; lamellipodium; and phagocytic cup. Predicted to be active in glutamatergic synapse; plasma membrane; and postsynapse. Orthologous to human ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase); PARTICIPATES IN epidermal growth factor/neuregulin signaling pathway; myocarditis pathway; INTERACTS WITH bisphenol A; C60 fullerene; dopamine.